Serum levels of soluble form of Fas molecule in patients with congestive heart failure

被引:67
作者
Okuyama, M
Yamaguchi, S
Nozaki, N
Yamaoka, M
Shirakabe, M
Tomoike, H
机构
[1] First Dept. of Internal Medicine, Yamagata University Medical School, Yamagata
关键词
D O I
10.1016/S0002-9149(97)00228-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Compared with soluble Fas molecule (sFas, an inhibitor of Fas-mediated apoptosis) in normal volunteers, the serum level of sFas significantly increased by 41% in New York Heart Association (NYHA) class III (p < 0.05) and by 97% in NYHA class IV patients with congestive heart failure (p < 0.001). Furthermore, sFas showed correlations with soluble forms of TNF receptor-p55 (RI) and -p75 (RII) (r = 0.68 and r = 0.56) which inhibit activities of TNF alpha.
引用
收藏
页码:1698 / &
页数:6
相关论文
共 25 条
[21]   2 TUMOR-NECROSIS-FACTOR RECEPTORS - STRUCTURE AND FUNCTION [J].
VANDENABEELE, P ;
DECLERCQ, W ;
BEYAERT, R ;
FIERS, W .
TRENDS IN CELL BIOLOGY, 1995, 5 (10) :392-399
[22]  
VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.immunol.10.1.411
[23]   Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both P55 and P75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures [J].
Williams, LM ;
Gibbons, DL ;
Gearing, A ;
Maini, RN ;
Feldmann, M ;
Brennan, FM .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (12) :2833-2841
[24]   CELLULAR BASIS FOR THE NEGATIVE INOTROPIC EFFECTS OF TUMOR-NECROSIS-FACTOR-ALPHA IN THE ADULT MAMMALIAN HEART [J].
YOKOYAMA, T ;
VACA, L ;
ROSSEN, RD ;
DURANTE, W ;
HAZARIKA, P ;
MANN, DL .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (05) :2303-2312
[25]   A CELL-KILLING MONOCLONAL-ANTIBODY (ANTI-FAS) TO A CELL-SURFACE ANTIGEN CO-DOWNREGULATED WITH THE RECEPTOR OF TUMOR NECROSIS FACTOR [J].
YONEHARA, S ;
ISHII, A ;
YONEHARA, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (05) :1747-1756